The therapeutic potential of cannabis has been known for centuries. Cannabinoids express their effects through two types of receptors, cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2). Present studies indicate that cannabis-based drugs can make a positive impact in the treatment of different diseases. For many years, multiple sclerosis patients have self-medicated with illegal street cannabis to alleviate spasticity, a common and debilitating symptom that impairs quality of life
Cannabinoids are compounds with pleiotropic properties that act on the cannabinoid receptors, CB1 an...
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spa...
Many people with MS (pwMS) use unregulated cannabis or cannabis products to treat the symptoms assoc...
© 2016, University of Kragujevac, Faculty of Science. All Rights Reserved. The therapeutic potential...
SITUATION: Multiple sclerosis belongs to the most common chronic neurological disease of the central...
A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impa...
Multiple sclerosis (MS) is known as an autoimmune disease that damages the neurons in the central ne...
Anna Maria Malfitano, Maria Chiara Proto, Maurizio BifulcoDipartimento di Scienze Farmaceutiche, Uni...
Background Multiple sclerosis is associated with muscle stiffness, spasms, pain, and tremor. Much...
Pharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plant-based cannabinoid...
Abstract—To estimate the patterns and prevalence of cannabis use among patients with multiple sclero...
The objective was to determine whether a cannabis-based medicinal extract (CBME) benefits a range of...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) and part of the...
Chronic relapsing experimental allergic encephalomyelitis (CREAE) is an autoimmune model of multiple...
Although extracts from the cannabis plant have been used medicinally for thousands of years, it is o...
Cannabinoids are compounds with pleiotropic properties that act on the cannabinoid receptors, CB1 an...
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spa...
Many people with MS (pwMS) use unregulated cannabis or cannabis products to treat the symptoms assoc...
© 2016, University of Kragujevac, Faculty of Science. All Rights Reserved. The therapeutic potential...
SITUATION: Multiple sclerosis belongs to the most common chronic neurological disease of the central...
A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impa...
Multiple sclerosis (MS) is known as an autoimmune disease that damages the neurons in the central ne...
Anna Maria Malfitano, Maria Chiara Proto, Maurizio BifulcoDipartimento di Scienze Farmaceutiche, Uni...
Background Multiple sclerosis is associated with muscle stiffness, spasms, pain, and tremor. Much...
Pharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plant-based cannabinoid...
Abstract—To estimate the patterns and prevalence of cannabis use among patients with multiple sclero...
The objective was to determine whether a cannabis-based medicinal extract (CBME) benefits a range of...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) and part of the...
Chronic relapsing experimental allergic encephalomyelitis (CREAE) is an autoimmune model of multiple...
Although extracts from the cannabis plant have been used medicinally for thousands of years, it is o...
Cannabinoids are compounds with pleiotropic properties that act on the cannabinoid receptors, CB1 an...
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spa...
Many people with MS (pwMS) use unregulated cannabis or cannabis products to treat the symptoms assoc...